Concepedia
Statistics
Publications
8
Citations
171
H-Index
Active since
1998
Affiliations
Orion Corporation (Finland)(Current)
University of Eastern Finland
University of Turku
Egis Pharmaceuticals (Hungary)
Egis (France)
Harri Kanerva is an author at Orion Corporation (Finland) specializing in pharmacology, pharmacy, and bioavailability.
Publications per year
1998–2005
Site dependent bioavailability and metabolism of levosimendan in dogs
Saila Antila, Hannele Huuskonen, Timo Nevalainen et al. · European Journal of Pharmaceutical Sciences · 1999 · 53 citations
Pharmacy, Pharmacokinetics, Pharmacology +7
Evaluation of novel starch acetate–diltiazem controlled release tablets in healthy human volunteers
Ossi Korhonen, Harri Kanerva, M Vidgren et al. · Journal of Controlled Release · 2004 · 46 citations
Pharmacy, Pharmaceutics, Pharmacology +14
Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study
Hannu Naukkarinen, Roope Raassina, Jukka Penttinen et al. · European Neuropsychopharmacology · 2005 · 17 citations
Medicine, Pharmacology, Psychiatry +14
The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers
Harri Kanerva, Olavi Kilkku, Esa Heinonen et al. · Biopharmaceutics & Drug Disposition · 1999 · 12 citations
Pharmacy, Pharmacokinetics, Pharmacology +12
Brain 5-HT 2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study
Harri Kanerva, Harry Vilkman, Kjell Någren et al. · Psychopharmacology · 1999 · 11 citations
Medicine, Neuroscience, Pharmacology +15
1–5 of 8